BioSig announces successful first-in-human use of PURE EP system
BioSig Technologies, a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Feb 19
BioSig Technologies, a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet…
21 Feb 19
Abiomed has now invested more than $100m over the past five years in clinical research on the Impella…
21 Feb 19
Neuspera Medical, a clinical stage, private venture capital backed neuromodulation company, has announced the final closing (2nd tranche)…
21 Feb 19
MagVenture, a Danish medical device company specializing in non-invasive magnetic stimulation systems to treat major depressive disorder and…
21 Feb 19
UK-based ReNeuron said that its its human retinal progenitor cells (hRPC) cell therapy candidate has demonstrated significant restoration…
21 Feb 19
Ocular Therapeutix has dosed the first patient in a phase 1 trial of tyrosine kinase inhibitor implant (OTX-TKI)…
21 Feb 19
Healthcare firm Abbott has secured CE mark approval for Determine HBsAg 2, which is claimed to be the…
20 Feb 19
Medical technology company Axonics Modulation Technologies has announced positive top-line clinical aata from its ARTISAN-Sacral Neuromodulation (SNM) pivotal…
20 Feb 19
Life sciences company LabCorp has introduced a new assay in its therapeutic drug monitoring (TDM) DoseASSURE portfolio, to…
20 Feb 19
Institut de Radiofarmacia Aplicada de Barcelona (IRAB), a leading producer of imaging biomarkers for use in clinical research,…